1535 related articles for article (PubMed ID: 17013474)
1. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
2. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
7. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
[TBL] [Abstract][Full Text] [Related]
8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.
Michos A; Terzidis A; Kalampoki V; Pantelakis K; Spanos T; Petridou ET
J Med Virol; 2008 May; 80(5):791-7. PubMed ID: 18360892
[TBL] [Abstract][Full Text] [Related]
10. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
11. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
12. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
[TBL] [Abstract][Full Text] [Related]
14. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of anti-HAV antibodies in Warsaw population].
Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
[TBL] [Abstract][Full Text] [Related]
16. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
Shapiro AJ; Esther CR; Leigh MW; Dellon EP
Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI
Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
19. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia.
Madani TA
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):278-83. PubMed ID: 16600318
[TBL] [Abstract][Full Text] [Related]
20. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.
Memish ZA; Knawy BA; El-Saed A
Int J Infect Dis; 2010 Feb; 14(2):e115-20. PubMed ID: 19540786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]